A new oral drug called daraxonrasib stunned researchers at this year’s ASCO conference in Chicago, slashing the risk of death from metastatic pancreatic cancer by 60%.
Chicago Doctors Hail ‘Game-Changing’ Pill That Doubles Pancreatic Cancer Survival — And It’s Already Changing Lives in America’s Biggest Cities
by | Jun 6, 2026 | Uncategorized | 0 comments
Recent Comments